Details for New Drug Application (NDA): 018279
✉ Email this page to a colleague
NDA 018279 describes K-TAB, which is a drug marketed by Abbvie and is included in one NDA. It is available from six suppliers. Additional details are available on the K-TAB profile page.
The generic ingredient in K-TAB is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-eight suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
The generic ingredient in K-TAB is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-eight suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
Summary for 018279
| Tradename: | K-TAB |
| Applicant: | Abbvie |
| Ingredient: | potassium chloride |
| Patents: | 0 |
Pharmacology for NDA: 018279
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Suppliers and Packaging for NDA: 018279
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| K-TAB | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 018279 | NDA | AbbVie Inc. | 0074-3023 | 0074-3023-13 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0074-3023-13) |
| K-TAB | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 018279 | NDA AUTHORIZED GENERIC | St. Mary's Medical Park Pharmacy | 60760-293 | 60760-293-90 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60760-293-90) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 8MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Aug 1, 1988 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 20MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Nov 25, 2013 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
